Roser Solans Laque Institutions of which they are part Main researcher Systemic Diseases Vall Hebron Institut de Recerca Email Roser Solans Laque Email Institutions of which they are part Main researcher Systemic Diseases Vall Hebron Institut de Recerca
Research lines Capillaroscopy abnormalities in primary Sjögren’s syndrome. We want to describe the capillaroscopy alterations observed in patients with Raynaud's phenomenon and primary Sjögren’s syndrome. Our main objective is to establish if there is a specific capillaroscopic pattern associated with Sjögren syndrome and if it is related to visceral extraglandular involvement. IP: Roser Solans Laque, Vicenç Fonollosa Pla Genetic bases of giant cell arteritis (GCA). With this study we aim to investigate the genetic background of the disease, to deepen in its pathogenesis and to be able to establish links between genetic variations and different clinic and biologic patterns. This research is based on a multicentric study and it is led by Prof. Javier Martín from the "Instituto López-Neyra" of Parasitology, CSIC (Granada). We contribute by sending samples from our cohort of patients along with the clinical data, and reviewing the results. IP: Roser Solans Laque Spanish Registry of patients with Systemic vasculitides (REVAS). This is a multicentre study supported by the Systemic Autoimmune Diseases Group (GEAS) from the Spanish Internal Medicine Society (SEMI). The aim of the study is to describe the different clinical forms of presentation of these diseases, the response to the conventional treatment of the different subtypes of vasculitides, and the prognostic factors and survival in our country. This study includes 17 Hospitals from Spain with a cohort of 300 patients. We are the study coordinator Centre. IP: Roser Solans Laque Cardiac involvement in Churg-Strauss Granulomatosis (EGPE). Cardiac involvement is one of the most important causes of dead in EGPE. The aim of this study is to investigate the prevalence of silent cardiac involvement in patients with EGPE, and if some chemotaxins (eotaxins 1, 2 and 3) may play a key role in its development, in order to establish an early tretament. IP: Roser Solans Laque Pagination Current page 1 Page 2 Page 3 Next page › Last page » Projects Ajuts Grups de Recerca (SGR) 2022 IP: Jaume Alijotas Reig Collaborators: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Ajuts Grups de Recerca (SGR) 2022, Ariadna Anunciacion Llunell Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00048 Duration: 01/01/2022 - 30/06/2025 Autoimmunitat i Malaltia Trombòtica (GRC) IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: Reference: 2014 SGR 329 Duration: 01/01/2014 - 31/12/2016 Estudio clínico e inmunológico de la afección cardíaca en fase de remisión clínica de la Poliangeítis con Granulomatosis eosinofílica IP: Roser Solans Laque Collaborators: - Funding agency: Mutual Mèdica de Catalunya i Balears Funding: 4000 Reference: 2014\BMM\SOLANS Duration: 27/11/2014 - 26/11/2015 Determinación del riesgo de afectación extraglandular y desarrollo de linfoma en el Síndrome de Sjögren primario mediante estudio de poblaciones linfocitarias y citocinas en sangre y tejido IP: Roser Solans Laque Collaborators: Carlos Palacio García, Margarita Alberola Ferranti, Fernando Martínez Valle Funding agency: Instituto de Salud Carlos III Funding: 35695 Reference: PI13/00655 Duration: 01/01/2014 - 30/06/2018 Pagination Current page 1 Page 2 Next page › Last page »
